Summit Wealth Group (Colorado)’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
Summit Wealth Group (Colorado)'s PJP Position: Q3 2026 in Review
Summit Wealth Group (Colorado) reduced its Invesco Pharmaceuticals ETF (PJP) stake by 3.9% in Q3 2026, selling an estimated $19.8K and leaving 3,904 shares worth $481K. The position accounts for 0.03% of the portfolio, ranked #270.
Summit Wealth Group (Colorado) first reported a position in PJP in Q2 2025 and has held it in 5 quarters since. 135 funds tracked by Wall St. Rank hold PJP as of Q3 2026.
- Summit Wealth Group (Colorado) held 3,904 shares of Invesco Pharmaceuticals ETF worth $481K as of Q3 2026.
- Summit Wealth Group (Colorado) sold 159 Invesco Pharmaceuticals ETF shares in Q3 2026, an estimated $19.8K.
- Invesco Pharmaceuticals ETF made up 0.03% of Summit Wealth Group (Colorado)'s portfolio in Q3 2026, its #270 holding.
- Summit Wealth Group (Colorado) first reported a position in Invesco Pharmaceuticals ETF in Q2 2025 and has held it in 5 quarters since.
- 135 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.
Based on Summit Wealth Group (Colorado)'s 13F filing for Q3 2026, filed 29 Oct 2026.